Abstract
The interaction of activated papain with low molecular weight cystatin (Mr 12500) purified from human placenta has been studied. Analysis of inhibition of caesinolytic activity of papain by cystatin showed stoichiometry of 1:1. Kinetic studies gave an inhibition constant (Ki) value of 5.5 x 10 -8 M and association rate constant (K+1) value of 3.4 x 10 4 (M-1 s-1). All spectroscopic studies showed conformational changes in both papain and cystatin on formation of complex. The data suggest perturbation of environment of aromatic residues and change of their native structure and conformation thereby shedding light on the behaviour of cystatins, especially interaction of placental cystatin with thiol protease inhibitors.
Keywords: cystatin, far uv-cd spectroscopy, fluorescence emission, human placenta, papain, uvabsorption
Protein & Peptide Letters
Title: Studies on the Interaction of Papain with Human Placental Cystatin by Uv, Fluorescence and Cd Spectroscopy
Volume: 11 Issue: 6
Author(s): Fouzia Rashid, S. P. Baba, Sandeep Sharma and B. Bano
Affiliation:
Keywords: cystatin, far uv-cd spectroscopy, fluorescence emission, human placenta, papain, uvabsorption
Abstract: The interaction of activated papain with low molecular weight cystatin (Mr 12500) purified from human placenta has been studied. Analysis of inhibition of caesinolytic activity of papain by cystatin showed stoichiometry of 1:1. Kinetic studies gave an inhibition constant (Ki) value of 5.5 x 10 -8 M and association rate constant (K+1) value of 3.4 x 10 4 (M-1 s-1). All spectroscopic studies showed conformational changes in both papain and cystatin on formation of complex. The data suggest perturbation of environment of aromatic residues and change of their native structure and conformation thereby shedding light on the behaviour of cystatins, especially interaction of placental cystatin with thiol protease inhibitors.
Export Options
About this article
Cite this article as:
Rashid Fouzia, Baba P. S., Sharma Sandeep and Bano B., Studies on the Interaction of Papain with Human Placental Cystatin by Uv, Fluorescence and Cd Spectroscopy, Protein & Peptide Letters 2004; 11 (6) . https://dx.doi.org/10.2174/0929866043406364
DOI https://dx.doi.org/10.2174/0929866043406364 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Current Drug Targets - Inflammation & Allergy Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research
Current Topics in Medicinal Chemistry Involvement of Coagulation and Hemostasis in Inflammatory Bowel Diseases
Current Vascular Pharmacology Microwaves-Assisted Syntheses of Imidazolylbenzamides and their Antioxidant Activities
Letters in Drug Design & Discovery Gold(III) Complexes in the Oncological Preclinical Arena: From Aminoderivatives to Peptidomimetics
Current Topics in Medicinal Chemistry Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
Current Pharmaceutical Design Cytotoxicity and Anti-Inflammatory Effects of Polyherbal Formulations, Joint Pain Spl and Rumalaya Forte on Lipopolysaccharide Induced Inflammation in IC-21 Macrophages
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Screens Based on the AlphaScreen™ Technology for Deciphering Cell Signalling Pathways
Current Genomics Potential Use of Dietary Natural Products, Especially Polyphenols, for Improving Type-1 Allergic Symptoms
Current Pharmaceutical Design The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis
Current Pharmaceutical Biotechnology Elucidating the Mechanism of Tofacitinib Oxidative Decyanation
Drug Metabolism Letters The Use of Biologic Therapies in the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Biotechnology Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases
Reviews on Recent Clinical Trials Current and Future Applications for Stem Cell Therapies in Spine Surgery
Current Stem Cell Research & Therapy Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract
Current Pharmaceutical Design Recent Development and Future Prospects of Plant-Based Vaccines
Current Drug Metabolism Catching the Therapeutic Window of Opportunity in Early Crohn`s Disease
Current Drug Targets Atom Based 3D-QSAR, Molecular Docking and Density Functional Theory Approaches to Identify Novel JNK-1 Inhibitor
Combinatorial Chemistry & High Throughput Screening Progress in Research of K<sub>V</sub>1.1 and K<sub>V</sub>1.3 Channels as Therapeutic Targets
Current Topics in Medicinal Chemistry Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design